Adaptimmune Therapeutics PLC (NASDAQ:ADAP) Short Interest Up 32.6% in August

Adaptimmune Therapeutics PLC (NASDAQ:ADAP – Get Free Report) was the target of a large increase in short interest in the month of August. As of August 15th, there was short interest totaling 11,070,000 shares, an increase of 32.6% from the July 31st total of 8,350,000 shares. Based on an average trading volume of 28,540,000 shares, […]

Leave a Reply

Your email address will not be published.

Previous post Achieve Life Sciences, Inc. (NASDAQ:ACHV) Short Interest Update
Next post Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Significant Growth in Short Interest